Showing 13 to 24 of 75 results
Cancer Mortality Decreases While New Cases Rise, Especially Among Young Adults
A 22 percent decrease in cancer mortality between 1973 and 2023 contrasts sharply with a 47 percent rise in new cases, particularly among young adults (20-49 years old), highlighting the impact of lifestyle and environmental factors.
Cancer Mortality Decreases While New Cases Rise, Especially Among Young Adults
A 22 percent decrease in cancer mortality between 1973 and 2023 contrasts sharply with a 47 percent rise in new cases, particularly among young adults (20-49 years old), highlighting the impact of lifestyle and environmental factors.
Progress
24% Bias Score
Exercise Program Significantly Improves Colon Cancer Survival Rates
A groundbreaking international study involving 889 colon cancer patients demonstrated that a three-year exercise program resulted in a 28% reduction in cancer recurrence and a 37% reduction in mortality, surpassing the expectations of researchers and highlighting the potential of exercise as a key c...
Exercise Program Significantly Improves Colon Cancer Survival Rates
A groundbreaking international study involving 889 colon cancer patients demonstrated that a three-year exercise program resulted in a 28% reduction in cancer recurrence and a 37% reduction in mortality, surpassing the expectations of researchers and highlighting the potential of exercise as a key c...
Progress
36% Bias Score
Exercise Improves Colon Cancer Survival by 37%, Study Shows
A Canadian study of 889 colon cancer patients showed that a structured three-year exercise program reduced mortality risk by 37% compared to an educational control group, establishing exercise as a new cancer treatment modality.
Exercise Improves Colon Cancer Survival by 37%, Study Shows
A Canadian study of 889 colon cancer patients showed that a structured three-year exercise program reduced mortality risk by 37% compared to an educational control group, establishing exercise as a new cancer treatment modality.
Progress
40% Bias Score
Camizestrant Shows Significant Promise in Treating Aggressive Breast Cancer
A clinical trial shows that the drug camizestrant significantly reduces the risk of progression or death in patients with HR-positive HER2-negative breast cancer who have the ESR1 mutation, a common cause of treatment resistance; the drug is being fast-tracked for approval in the US and UK.
Camizestrant Shows Significant Promise in Treating Aggressive Breast Cancer
A clinical trial shows that the drug camizestrant significantly reduces the risk of progression or death in patients with HR-positive HER2-negative breast cancer who have the ESR1 mutation, a common cause of treatment resistance; the drug is being fast-tracked for approval in the US and UK.
Progress
56% Bias Score
Liquid Biopsies Improve Metastatic Breast Cancer Treatment
A new study published in The New England Journal of Medicine demonstrates that liquid biopsies can detect breast cancer mutations up to nine months earlier than imaging tests, enabling earlier treatment changes and improving patient outcomes; patients who switched treatments based on liquid biopsy r...
Liquid Biopsies Improve Metastatic Breast Cancer Treatment
A new study published in The New England Journal of Medicine demonstrates that liquid biopsies can detect breast cancer mutations up to nine months earlier than imaging tests, enabling earlier treatment changes and improving patient outcomes; patients who switched treatments based on liquid biopsy r...
Progress
52% Bias Score
AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
AI Test Improves Prostate Cancer Treatment Outcomes
A new AI test predicts which men with high-risk prostate cancer will benefit from abiraterone, a drug that halves the risk of death for 25% of patients; this was tested on over 1,000 men and may lead to wider access to the drug.
Progress
48% Bias Score
New 'Smart Bomb' Cancer Treatment Shows Significant Improvement in HER2-Positive Metastatic Breast Cancer
A clinical trial involving nearly 400 patients with HER2-positive metastatic breast cancer showed that a new treatment combining T-DXd and pertuzumab reduced disease progression or death risk by 44%, with 15% achieving complete remission, compared to 8.5% with standard therapy; the findings will be ...
New 'Smart Bomb' Cancer Treatment Shows Significant Improvement in HER2-Positive Metastatic Breast Cancer
A clinical trial involving nearly 400 patients with HER2-positive metastatic breast cancer showed that a new treatment combining T-DXd and pertuzumab reduced disease progression or death risk by 44%, with 15% achieving complete remission, compared to 8.5% with standard therapy; the findings will be ...
Progress
48% Bias Score
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Progress
36% Bias Score
Car T-cell Immunotherapy Extends Life of Gastric Cancer Patients by 40%
A world-first clinical trial in China shows that Car T-cell immunotherapy significantly increases the lifespan of patients with advanced gastric or gastro-oesophageal junction cancer by approximately 40%, offering a potential paradigm shift in the treatment of solid tumors, according to results publ...
Car T-cell Immunotherapy Extends Life of Gastric Cancer Patients by 40%
A world-first clinical trial in China shows that Car T-cell immunotherapy significantly increases the lifespan of patients with advanced gastric or gastro-oesophageal junction cancer by approximately 40%, offering a potential paradigm shift in the treatment of solid tumors, according to results publ...
Progress
48% Bias Score
Exercise, Diet, and New Drug Show Promise in Combating Colorectal Cancer
New studies show that regular exercise and an anti-inflammatory diet significantly improve survival rates for colorectal cancer patients, while a new drug, Braftovi, doubled survival time for patients with an aggressive form of the disease in clinical trials.
Exercise, Diet, and New Drug Show Promise in Combating Colorectal Cancer
New studies show that regular exercise and an anti-inflammatory diet significantly improve survival rates for colorectal cancer patients, while a new drug, Braftovi, doubled survival time for patients with an aggressive form of the disease in clinical trials.
Progress
16% Bias Score
Exercise Significantly Reduces Colon Cancer Recurrence Risk
A study of nearly 900 colon cancer patients found that a structured exercise program following surgery and chemotherapy reduced the risk of recurrence, new diagnosis, or death by 28%, suggesting exercise as a vital post-treatment therapy.
Exercise Significantly Reduces Colon Cancer Recurrence Risk
A study of nearly 900 colon cancer patients found that a structured exercise program following surgery and chemotherapy reduced the risk of recurrence, new diagnosis, or death by 28%, suggesting exercise as a vital post-treatment therapy.
Progress
28% Bias Score
Voronezh Oncology Center Warns of Laryngeal Cancer Risks
The Voronezh Regional Oncology Center warns of laryngeal cancer, highlighting risk factors (smoking, alcohol, occupational hazards, HPV, poor diet, chronic conditions) and symptoms (hoarseness, throat pain, cough, breathing difficulties). Prevention focuses on lifestyle changes and early detection.
Voronezh Oncology Center Warns of Laryngeal Cancer Risks
The Voronezh Regional Oncology Center warns of laryngeal cancer, highlighting risk factors (smoking, alcohol, occupational hazards, HPV, poor diet, chronic conditions) and symptoms (hoarseness, throat pain, cough, breathing difficulties). Prevention focuses on lifestyle changes and early detection.
Progress
0% Bias Score
Showing 13 to 24 of 75 results